Congressional Funding Status
The Department of Health and Human Services (HHS), including NIH, is operating under the Consolidated Appropriations Act, 2023 (Public Law 117-328), signed by President Biden on December 29, 2022. This law continues government operations through September 30, 2023.
Competing Award Administrative Reductions and Funding Policies
- Non-Modular R01s will receive a 17.5% administrative cut; modular R01s and most other funding mechanisms are generally awarded with no administrative reduction to the IRG-approved funding level.
- Salaries, stipends, and Training Funds are limited to the levels published by the NIH. We will reduce budgets when these caps are exceeded. For additional information, see our salary cap, stipends, and training funds page.
- No inflationary increases are provided in calculating future year commitments. For more details about this and related funding policies, see our Funding Policies page.
Noncompeting Award Funding Policies
-
When an application is funded, NIH agrees to provide funds over several years (for example, the typical NINDS R01 award is funded for five years). Therefore, investigators request payment for the next budget period (usually, every year), but these requests do not compete with other applications. NINDS will pay FY23 non-competing continuation awards at their full committed level as shown in the Notice of Award and will restore any cuts made in non-competing awards paid earlier in this fiscal year.
Understanding Your Funding Likelihood
The tables below provide guidelines to applicants trying to assess their likelihood of funding. There are a few important points of note that applicants must keep in mind when reviewing this information:
Key Points
- Funding isn’t official until a Notice of Award (NoA) is issued.
- NINDS Program Staff are not able to say anything more definitive until after the NINDS Advisory Council meets and the NoA has been released.
- You can find more details on how to assess funding likelihood and when that determination is likely to be made by visiting the NINDS Post Review: Next Steps page.
Applications with a Percentile Score
This table applies to applications receiving a percentiled score. While a score within the paylines shown in the table below suggests a high likelihood of funding, it is not a guarantee; there are rare circumstances where an application within the payline is not funded.
|
Applicant has >$2M in NIH Funding^ |
Standard |
Early Stage Investigator (ESI) |
AD/ADRD* |
AD/ADRD* ESI |
---|---|---|---|---|---|
R03 |
7% |
14% |
N/A |
25% |
N/A |
R15 |
7% |
14% |
N/A |
25% |
N/A |
R21 |
7% |
14% |
N/A |
25% |
N/A |
R01 |
7% |
14% |
25% |
25% |
30% |
^ Applications with greater than $2 million in NIH funding are subject to Special Council Review.
*For AD/ADRD applications, NINDS follows the same payline as NIA. Please see the NIA Funding Line Policy for more information.
Non-percentiled applications
This table applies to applications receiving only a priority score. There are no paylines for non-percentiled applications; rather, applications are individually considered and assessed for portfolio balance based on funds available. The table below is intended to give investigators an indication of their likelihood of funding based on recent trends. It is not intended to suggest that funding at a particular score is guaranteed.
SBIR/STTR
Most applications funded (>75%) | Some applications funded | Few applications funded | |
---|---|---|---|
R41 | ≤ 25 | 26 - 35 | > 35 |
R42 | ≤ 25 | 26 - 30 | > 30 |
R43 | ≤ 25 | 26 - 30 | > 30 |
R44 | ≤ 22 | 23 - 30 | > 30 |
SB1 | ≤ 22 | 23 - 30 | > 30 |
U44 | ≤ 25 | 26 - 30 | > 30 |
Fellowships, Training, Career Development, Research Education
Most applications funded (>75%) | Some applications funded | Few applications funded | |
---|---|---|---|
F30 | ≤ 30 | 31 - 35 | > 35 |
F31 | ≤ 20 | 21 - 26 | > 26 |
F32 | ≤ 30 | 31 - 37 | > 37 |
F99 | ≤ 35 | 36 - 40 | > 40 |
K01 | ≤ 30 | 31 - 45 | > 45 |
K08 | ≤ 30 | 31 - 40 | > 40 |
K23 | ≤ 30 | 31 - 37 | > 37 |
K99 | ≤ 30 | 31 - 37 | > 37 |
R25 | ≤ 30 | 31 - 40 | > 40 |
T32 | ≤ 30 | 31 - 35 | > 35 |
Other Research Grants
Most applications funded (>75%) | Some applications funded | Few applications funded | |
---|---|---|---|
P01 | ≤ 25 | 26 - 30 | > 30 |
P50 | ≤ 25 | 26 - 30 | > 30 |
R34 | ≤ 30 | 31 - 40 | > 40 |
R35 | ≤ 25 | 26 - 30 | > 30 |
R61/R33 | ≤ 25 | 26 - 30 | > 30 |
U01 | ≤ 25 | 26 - 30 | > 30 |
U19 | ≤ 30 | 31 - 40 | > 40 |
U54 | ≤ 25 | 26 - 30 | > 30 |
UG3/UH3 | ≤ 30 | 31 - 35 | > 35 |